Physician profile
Andre Dean Frederick
NPI 1932308384
$718.44
in general payments reported to CMS, 2019-2025
16 companies · $25.06 in 2025
The $25.06 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $61.52 · 2021: $106 · 2022: $142 · 2023: $125 · 2024: $92.62 · 2025: $25.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $140.64 | 2021-2024 | Recarbrio, Dificid, Zerbaxa |
| Gilead Sciences, INC. | $124.99 | 2023 | Epclusa |
| Astrazeneca Pharmaceuticals LP | $90.24 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $67.03 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.12 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $41.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $37.40 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $30.77 | 2019 | |
| Masimo Corporation | $25.06 | 2025 | Set and Rainbow Set |
| Allergan, INC. | $18.69 | 2019 | |
| Alkermes, INC. | $18.47 | 2019 | |
| Smith+Nephew, INC. | $18.27 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.55 | 2022 | |
| Pfizer INC. | $13.23 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.